Ilyang Pharmaceutical Co.,Ltd (007570.KS) KSC

13,050.00

+10(+0.08%)

Updated at September 12 07:48AM

Currency In KRW

Valuation

Market Cap210.12B
Enterprise Value313.5B
P/E Ratio20.81
PEG Ratio-5.54
Price/Sales Ratio1.01
Price/Book Ratio0.99
Enterprise/Revenue1.51
Enterprise/EBITDA7.51

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.05
Operating Margin0.04

Management Effectiveness

Return On Assets0.03
Return On Equity0.05

Income Statement

Revenue268.86B
Revenue/Share12,937
Gross Profit111.48B
EBITDA25.03B
Net Income10.26B
Diluted EPS557

Balance Sheet

Total Cash16.58B
Total Cash/Share923.08
Total Debt122.36B
Total Debt/Equity0.52
Current Ratio0.87
Book Value Per Share13,330.04

Price History

52-Week Change1.01
52-Week High15,490
52-Week Low9,540
Moving Average 50 Days13,197.8
Moving Average 200 Days12,070.55

Statistics

Average Volume56,022
Shares Outstanding17.95M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate150
Trailing Annual Dividend Yield1.15
Payout Ratio0.18
Last Split Factor131:125
Last Split DateMarch 04, 2011